Need professional-grade analysis? Visit stockanalysis.com
$203.75M
N/A
N/A
N/A
Jyong Biotech Ltd. Ordinary Shares (MENS) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $2.13, down 12.70% from the previous close.
Over the past year, MENS has traded between a low of $1.46 and a high of $65.62. The stock has lost 78.9% over this period. It is currently 96.8% below its 52-week high.
Jyong Biotech Ltd. Ordinary Shares has a market capitalization of $203.75M.
Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Side-by-side comparison against top Healthcare peers.